R. Jonathan Henderson, MD, discusses incorporating immunotherapy agents into practice in patients with bladder cancer.
R. Jonathan Henderson, MD
Advertisement
Articles by R. Jonathan Henderson, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Vorasidenib Elicits Early Metabolic Responses in IDH-Mutant Glioma
2
Cross Currents: New Frontiers in ADC Therapy for Breast Cancer
3
Mirdametinib Deepens Responses in NF1-Associated Plexiform Neurofibroma
4
Dr Forde on Selecting Neoadjuvant and Perioperative Immunotherapy in Resectable NSCLC
5